RICHARDSON M, HOLT J N
J Bacteriol. 1962 Oct;84(4):638-46. doi: 10.1128/jb.84.4.638-646.1962.
Richardson, Marvis (Michigan State University, East Lansing) and Jane N. Holt. Synergistic action of streptomycin with other antibiotics on intracellular Brucella abortus in vitro. J. Bacteriol. 84:638-646. 1962.-It has been found that streptomycin acts synergistically with penicillin and tetracycline to inhibit the growth of Brucella abortus within bovine cells cultured in vitro. Extracellular penicillin at 10 to 50 mug/ml was essentially bacteriostatic for intracellular brucellae. A combination of 5 to 50 mug/ml of streptomycin, which alone did not prevent the multiplication of intracellular brucellae, and 50 mug/ml of penicillin was bactericidal. Tetracycline at 0.5 to 1.0 mug/ml, which permitted growth or was bacteriostatic for brucellae within tissue cells, proved markedly bactericidal when combined with 10 mug/ml of streptomycin. Within certain limits, the synergistic effect of streptomycin and tetracycline did not appear to be a function of concentration. When the addition of streptomycin was delayed until 24 hr after the addition of tetracycline, the antibiotics acted synergistically on intracellular brucellae. To achieve intracellular synergism, five to ten times the effective extracellular concentration of streptomycin was required. Penicillin and tetracycline acted at the same concentration on extracellular and intracellular brucellae. These results suggest that tissue cell systems may prove useful for study of multiple drug therapy to be used in vivo against intracellular bacteria.
理查森,马维斯(密歇根州立大学,东兰辛)和简·N·霍尔特。链霉素与其他抗生素对体外细胞内流产布鲁氏菌的协同作用。《细菌学杂志》84:638 - 646。1962年。——已发现链霉素与青霉素和四环素协同作用,抑制体外培养的牛细胞内流产布鲁氏菌的生长。细胞外青霉素浓度为10至50微克/毫升时,对细胞内布鲁氏菌基本起抑菌作用。5至50微克/毫升的链霉素单独使用时不能阻止细胞内布鲁氏菌的繁殖,与50微克/毫升的青霉素联合使用则具有杀菌作用。0.5至1.0微克/毫升的四环素可使组织细胞内的布鲁氏菌生长或起抑菌作用,但与10微克/毫升的链霉素联合使用时则具有明显的杀菌作用。在一定限度内,链霉素和四环素的协同作用似乎不是浓度的函数。当链霉素的添加延迟到四环素添加后24小时时,这两种抗生素对细胞内布鲁氏菌仍有协同作用。为实现细胞内协同作用,所需链霉素的细胞外有效浓度是其五至十倍。青霉素和四环素在相同浓度下对细胞外和细胞内布鲁氏菌均有作用。这些结果表明,组织细胞系统可能对研究体内用于对抗细胞内细菌的联合药物疗法有用。